Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3

FEBS Letters

Volumn 578, Issue 1-2, 2004, Pages 116-120

  Mailliet, François ^a   Ferry, Gilles ^a   Vella, Fanny ^a   Thiam, Kader ^b   Delagrange, Philippe ^a   Boutin, Jean A ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b genOway   (France)

Author keywords

Dihydronicotinamide riboside:quinone oxidoreductase 2; Knock out mice: Quinone reductase 1; Melatonin receptor; MT3

Indexed keywords

DIHYDRONICOTINAMIDE RIBOSIDE:QUINONE REDUCTASE 2; IODINE 125; MELATONIN RECEPTOR; OXIDOREDUCTASE; RADIOLIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BINDING SITES; BRAIN; GENE TARGETING; IODINE RADIOISOTOPES; KIDNEY; MELATONIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; QUINONE REDUCTASES; RADIOLIGAND ASSAY; RECEPTORS, MELATONIN;

EID: 9644278439     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.10.083     Document Type: Article

References (34)

1. J.R. Redman, S.M. Armstrong, and K.T. Hg Free-running activity rhythms in the rat: entrainment by melatonin Science 219 1983 1089 1091
2. P. Delagrange, J. Atkinson, J.A. Boutin, L. Casteilla, D. Lesieur, R. Misslin, S. Pellissier, L. Penicaud, and P. Renard Therapeutic perspectives for melatonin agonists and antagonists J. Neuroendocrinol. 15 2003 442 448
3. P. Delagrange, and B. Guardiola-Lemaître Melatonin, its receptors, and relationships with biological rhythm disorders Clin. Neuropharmacol. 20 1997 482 510
4. P.J. Morgan, P. Barrett, H.E. Howell, and R. Helliwell Melatonin receptors: localization, molecular pharmacology and physiological significance Neurochem. Int. 24 1994 101 146
5. R. Hardeland, and B. Fuhrberg Ubiquitous melatonin - presence and effects in unicells, plants and animals Trends Comp. Biochem. Physiol. 2 1996 25 45
6. S.M. Reppert, D.R. Weaver, and T. Ebisawa Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses Neuron 13 1994 1177 1185
7. S.M. Reppert, C. Godson, C.D. Mahle, D.R. Weaver, S.A. Slaugenhaupt, and J.F. Gusella Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor Proc. Natl. Acad. Sci. USA 92 1995 8734 8738
8. V. Audinot, F. Mailliet, C. Lahaye-Brasseur, A. Bonnaud, A. Le Gall, C. Amosse, S. Dromaint, M. Rodriguez, N. Nagel, J.P. Galizzi, B. Malpaux, G. Guillaumet, D. Lesieur, F. Lefoulon, P. Renard, P. Delagrange, and J.A. Boutin New selective ligands of human cloned melatonin MT1 and MT2 receptors Naunyn-Schmiedeberg's Arch. Pharmacol. 367 2003 553 561
9. F. Mailliet, V. Audinot, B. Malpaux, A. Bonnaud, P. Delagrange, M. Migaud, P. Barrett, M.C. Viaud-Massuard, D. Lesieur, F. Lefoulon, P. Renard, and J.A. Boutin Molecular pharmacology of the ovine melatonin receptor: comparison with recombinant human MT1 and MT2 receptors Biochem. Pharmacol. 67 2004 667 677
10. M.L. Dubocovich, D.P. Cardinali, P. Delagrange, D.N. Krause, A.D. Strosberg, D. Sugden, and F.D. Yocca The IUPHAR Compendium of Receptor Characterization and Classification 2000 IUPHAR Media London pp. 270-277
11. S.M. Reppert, and D.R. Weaver Melatonin madness Cell 83 1995 1059 1062
12. T. Ebisawa, S. Karne, M.R. Lerner, and S.M. Reppert Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores Proc. Natl. Acad. Sci. USA 91 1994 6133 6137
13. 125I] iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution Endocrinology 122 1988 1825 1833
14. D.S. Pickering, and L.P. Niles Pharmacological characterization of melatonin binding sites in Syrian hamster hypothalamus Eur. J. Pharmacol. 175 1990 71 77
15. 125I]iodo-5- methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites Eur. J. Pharmacol. 301 1996 159 168
16. 125I]iodomelatonin binding sites in Syrian hamster peripheral organs J. Pharmacol. Exp. Ther. 290 1999 334 340
17. O. Nosjean, J.P. Nicolas, F. Klupsch, P. Delagrange, E. Canet, and J.A. Boutin Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2 Biochem. Pharmacol. 61 2001 1369 1379
18. L. Petit, I. Lacroix, P. de Coppet, A.D. Strosberg, and R. Jockers Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3′-5′-monophosphate pathway Biochem. Pharmacol. 58 1999 633 639
19. L. Brydon, F. Roka, L. Petit, P. de Coppet, M. Tissot, P. Barrett, P.J. Morgan, C. Nanoff, A.D. Strosberg, and R. Jockers Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins Mol. Endocrinol. 13 1999 2025 2038
20. V. Leclerc, S. Yous, P. Delagrange, J.A. Boutin, P. Renard, and D.J. Lesieur Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3) Med. Chem. 45 2002 1853 1859
21. O. Nosjean, M. Ferro, F. Coge, P. Beauverger, J.M. Henlin, F. Lefoulon, J.L. Fauchere, P. Delagrange, E. Canet, and J.A. Boutin Identification of the melatonin-binding site MT3 as the quinone reductase 2 J. Biol. Chem. 275 2000 31311 31317
22. A.K. Jaiswal, P. Burnett, M. Adesnik, and O.W. McBride Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6 Biochemistry 29 1990 1899 1906
23. Q. Zhao, X.L. Yang, W.D. Holtzclaw, and P. Talalay Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase) Proc. Natl. Acad. Sci. USA 94 1997 1669 1674
24. D.J. Long, K. Iskander, A. Gaikwad, M. Arin, D.R. Roop, R. Knox, R. Barrios, and A.K. Jaiswal Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity J. Biol. Chem. 277 2002 46131 46139
25. L. Iacovitti, N.D. Stull, and K. Johnston Melatonin rescues dopamine neurons from cell death in tissue culture models of oxidative stress Brain Res 768 1997 317 326
26. 2-induced lipid peroxidation in rat brain homogenates is greatly reduced by melatonin Neurosci. Lett. 195 1995 203 205
27. D.C. Skinner, and B. Malpaux High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus Endocrinology 140 1999 4399 4405
28. A. Carrillo-Vico, J.R. Calvo, P. Abreu, P.J. Lardone, S. Garcia-Maurino, R.J. Reiter, and J.M. Guerrero Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance FASEB J. 18 2004 537 539
29. R.J. Reiter, R.M. Sainz, S. Lopez-Burillo, J.C. Mayo, L.C. Manchester, and D.X. Tan Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke N Y Acad. Sci. 993 2003 35 47
30. R.J. Reiter, and D.X. Tan Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart Cardiovasc. Res. 58 2003 10 19
31. K. Yeleswaram, L.G. McLaughlin, J.O. Knipe, and D. Schabdach Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications J. Pineal Res. 22 1997 45 51
32. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
33. Y.H. Edwards, J. Potter, and D.A. Hopkinson Human FAD-dependent NAD(P)H diaphorase Biochem. J. 187 1980 429 436
34. Z. Zhou, D. Fisher, J. Spidel, J. Greenfield, B. Patson, A. Fazal, C. Wigal, O.A. Moe, and J.D. Madura Kinetic and docking studies of the interaction of quinones with the quinone reductase active site Biochemistry 42 2003 1985 1994